Merck executives share their strategy for embedding health equity across the pharma value chain.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate Vice President for Health Equity and Lead, Merck for Mothers
Former Executive Director of Health Equity, Merck

New standards for data interoperability could redefine the value proposition for payers, providers, and patients.

Chief Strategy Officer, 1upHealth

Cell and gene therapies hold tremendous promise for patients and the industry, but new business models are needed to get innovations to patients.

Principal, Health and Life Sciences, Oliver Wyman

Marsh McLennan Advantage

High-income countries have, on average, administered nearly 25 times more doses of coronavirus vaccines than low-income countries.

Winning back talent is becoming the fight of our lives.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

Insights in your inbox

Subscribe

Using health IT to tackle health equity and opening multiple front doors for patients were a couple of themes that emerged at three big health conferences.

Senior Editor, Health and Life Sciences, Oliver Wyman

In today's hyperconnected world, organizations have to work together to defend against cyber attacks. And they need to embed secure technology and procedures more widely.

Partner, Digital and Financial Services, Cyber Platform Lead, Oliver Wyman
Senior Advisor, Oliver Wyman

While women were more likely to consider seeking mental health support during the pandemic, men were more prone to getting care.

Partner, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Knowledge Expert, Oliver Wyman
Lead Data Scientist, Health and Life Sciences, Oliver Wyman

As the Biden administration leans into the Cancer Moonshot 2.0, the life sciences industry has the opportunity to launch a new era of precision oncology. How can we accelerate progress toward truly personalized medicine and revolutionize cancer care?

President and CEO, COTA, Inc.

CMS released the next evolution of Direct Contracting, boosting the program’s attractiveness and its focus on health equity, as well as scrapping the Geo program.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Actuarial Consulting, Oliver Wyman

Insights in your inbox

Subscribe
Load More